Leveraging the dominant-negative effect of the kuru-protective G127V prion protein variant as a novel therapeutic strategy.
- DOI
- 10.1016/j.nbd.2026.107506
- Published
- 2026-06-29
- Container
- Neurobiol Dis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.nbd.2026.107506,
title = {Leveraging the dominant-negative effect of the kuru-protective G127V prion protein variant as a novel therapeutic strategy.},
author = {Gatdula JRP and Mirza-Romero NA and Orbe IC and Saunders LM and Tolton SG and Vultaggio JS and Mercer RCC and Bartz JC and Telling GC and Eraña H and Castilla J and Harris DA.},
year = {2026},
journal = {Neurobiol Dis},
doi = {10.1016/j.nbd.2026.107506},
url = {https://doi.org/10.1016/j.nbd.2026.107506}
}RIS
TY - JOUR TI - Leveraging the dominant-negative effect of the kuru-protective G127V prion protein variant as a novel therapeutic strategy. AU - Gatdula JRP AU - Mirza-Romero NA AU - Orbe IC AU - Saunders LM AU - Tolton SG AU - Vultaggio JS AU - Mercer RCC AU - Bartz JC AU - Telling GC AU - Eraña H AU - Castilla J AU - Harris DA. PY - 2026 JO - Neurobiol Dis DO - 10.1016/j.nbd.2026.107506 UR - https://doi.org/10.1016/j.nbd.2026.107506 ER -
APA
JRP, G., NA, M., IC, O., LM, S., SG, T., JS, V., RCC, M., JC, B., GC, T., H, E., J, C., & DA., H. (2026). Leveraging the dominant-negative effect of the kuru-protective G127V prion protein variant as a novel therapeutic strategy.. Neurobiol Dis. https://doi.org/10.1016/j.nbd.2026.107506
Source records
- europe-pmc · retrieved 2026-09-26T18:49:18.733Z